CA2363496A1 - Differential expression of organellar gene products - Google Patents
Differential expression of organellar gene products Download PDFInfo
- Publication number
- CA2363496A1 CA2363496A1 CA002363496A CA2363496A CA2363496A1 CA 2363496 A1 CA2363496 A1 CA 2363496A1 CA 002363496 A CA002363496 A CA 002363496A CA 2363496 A CA2363496 A CA 2363496A CA 2363496 A1 CA2363496 A1 CA 2363496A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- cell
- state
- interest
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12467399P | 1999-03-16 | 1999-03-16 | |
US60/124,673 | 1999-03-16 | ||
US52697700A | 2000-03-15 | 2000-03-15 | |
US09/526,977 | 2000-03-15 | ||
PCT/US2000/007311 WO2000055323A1 (en) | 1999-03-16 | 2000-03-16 | Differential expression of organellar gene products |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2363496A1 true CA2363496A1 (en) | 2000-09-21 |
Family
ID=26822840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002363496A Abandoned CA2363496A1 (en) | 1999-03-16 | 2000-03-16 | Differential expression of organellar gene products |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1161534A1 (ja) |
JP (1) | JP2003524397A (ja) |
AU (1) | AU3900600A (ja) |
CA (1) | CA2363496A1 (ja) |
WO (1) | WO2000055323A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003020220A2 (en) * | 2001-08-30 | 2003-03-13 | Emory University | Mitochondrial biology expression arrays |
JPWO2005074988A1 (ja) * | 2004-02-06 | 2007-10-11 | 株式会社ロコモジェン | 神経細胞分化誘導剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69535428T2 (de) * | 1994-02-14 | 2007-12-06 | Smithkline Beecham Corp. | Verfahren zum Auffinden von differentiel exprimierte Gene |
AU705230B2 (en) * | 1994-03-30 | 1999-05-20 | Mitokor | Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
US5840493A (en) * | 1994-03-30 | 1998-11-24 | Mitokor | Mitochondrial DNA mutations that segregate with late onset diabetes mellitus |
EP0904277A4 (en) * | 1996-02-16 | 2003-01-22 | Millennium Pharm Inc | COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CARDIOVASCULAR DISEASES |
IL129872A0 (en) * | 1996-11-12 | 2000-02-29 | Qbi Entpr Ltd | Method for identifying translationally regulated genes |
-
2000
- 2000-03-16 JP JP2000605741A patent/JP2003524397A/ja not_active Withdrawn
- 2000-03-16 WO PCT/US2000/007311 patent/WO2000055323A1/en active Search and Examination
- 2000-03-16 AU AU39006/00A patent/AU3900600A/en not_active Abandoned
- 2000-03-16 EP EP00918143A patent/EP1161534A1/en not_active Withdrawn
- 2000-03-16 CA CA002363496A patent/CA2363496A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1161534A1 (en) | 2001-12-12 |
WO2000055323A1 (en) | 2000-09-21 |
AU3900600A (en) | 2000-10-04 |
JP2003524397A (ja) | 2003-08-19 |
WO2000055323A9 (en) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kantheti et al. | Mutation in AP-3 δ in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles | |
Vassalli et al. | Minigenes impart odorant receptor-specific axon guidance in the olfactory bulb | |
Chen et al. | Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. | |
Sato et al. | The AtVAM3 encodes a syntaxin-related molecule implicated in the vacuolar assembly in Arabidopsis thaliana | |
EP0656954B1 (en) | Method for producing tagged genes, transcripts, and proteins | |
AU2017293773A1 (en) | CRISPR/Cas9-based compositions and methods for treating retinal degenerations | |
Rudner et al. | Mutations in the small subunit of the Drosophila U2AF splicing factor cause lethality and developmental defects. | |
KR20200006054A (ko) | 신규 타입 vi crispr 오르소로그 및 시스템 | |
KR20210077732A (ko) | Nme2cas9-데아미나아제 융합 단백질에 의한 프로그램 가능한 dna 염기 편집 | |
US20040072739A1 (en) | Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes | |
US20020049176A1 (en) | Modulation of mitochondrial mass and function for the treatment of diseases and for target and drug discovery | |
Lee et al. | Gene knockouts reveal separate functions for two cytoplasmic dyneins in Tetrahymena thermophila | |
Corydon et al. | Human and mouse mitochondrial orthologs of bacterial ClpX | |
JP2023113657A (ja) | B4galt1バリアント及びその使用 | |
Kim et al. | A nucleolar protein that affects mating efficiency in Saccharomyces cerevisiae by altering the morphological response to pheromone | |
CA2363496A1 (en) | Differential expression of organellar gene products | |
US20170355956A1 (en) | Compositions for increasing survival of motor neuron protein (smn) levels in target cells and methods of use thereof for the treatment of spinal muscular atrophy | |
EP0927046A1 (en) | Mammalian regulator of nonsense-mediated rna decay | |
CA2390646A1 (en) | Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes | |
US20210284979A1 (en) | Methods and compositions for genetically manipulating genes and cells | |
JP2003235575A (ja) | 哺乳動物において機能的なトランスポゾン | |
US20030026781A1 (en) | Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes | |
US20220316008A1 (en) | Compositions comprising rare genetic sequence variants associated with pulmonary function and methods of use thereof for diagnosis and treatment of asthma in african american patients | |
Degl'Innocenti et al. | ACYP1 gene possesses two alternative splicing forms that induce apoptosis | |
Ye et al. | Low grain weight, a new allele of BRITTLE CULM12, affects grain size through regulating GW7 expression in rice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |